- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aspire Biopharma Holdings Inc (ASBP)
Aspire Biopharma Holdings Inc stock price live, this page displays NASDAQ ASBP stock exchange data. View the ASBP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aspire Biopharma Holdings Inc real time stock price chart below.
What Is the Aspire Biopharma Holdings Inc Stock Price Today?
The Aspire Biopharma Holdings Inc stock price today is 9.0600.
What Is the Stock Symbol for Aspire Biopharma Holdings Inc?
The stock symbol for Aspire Biopharma Holdings Inc is "ASBP."
What Stock Exchange Does Aspire Biopharma Holdings Inc Trade On?
Aspire Biopharma Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Aspire Biopharma Holdings Inc a Good Stock to Buy?
Determining whether Aspire Biopharma Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASBP quote. (ISIN: US7389203057)
What Is the Aspire Biopharma Holdings Inc Stock Price Today?
The Aspire Biopharma Holdings Inc stock price today is 9.0600.
What Is the Stock Symbol for Aspire Biopharma Holdings Inc?
The stock symbol for Aspire Biopharma Holdings Inc is "ASBP."
What Stock Exchange Does Aspire Biopharma Holdings Inc Trade On?
Aspire Biopharma Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Aspire Biopharma Holdings Inc a Good Stock to Buy?
Determining whether Aspire Biopharma Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASBP quote. (ISIN: US7389203057)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.0600
9.3783
52 wk Range
3.3090
562.9200
ASBP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.06009.3783
52 wk Range
3.3090562.9200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ASBP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Aspire Biopharma acquires automotive supplier DCS for $30M- Investing.com
Pro
Form 8K Aspire Biopharma Holdings Inc For: 19 August- Investing.com
- Form 8K Aspire Biopharma Holdings Inc For: 19 August
- Investing.com
Form 8K Aspire Biopharma Holdings Inc For: 10 August- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-1.22 / --
Revenue / Forecast
63.1K / --
Compare ASBP to Peers and Sector
Metrics to compare | ASBP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASBPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −1.3x | −0.4x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 1.1x | 2.2x | 2.6x | |
Price / LTM Sales | 130.1x | 2.8x | 3.0x | |
Upside (Analyst Target) | - | 132.7% | 55.1% | |
Fair Value Upside | Unlock | 15.0% | 8.2% | Unlock |
Aspire-Lakewood Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2021. The company was founded in 2021 and is headquartered in Estero, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aspire Biopharma Holdings (ASBP) Stock Price Today?
The Aspire Biopharma Holdings stock price today is 9.0600 USD.
What Stock Exchange Does Aspire Biopharma Holdings Trade On?
Aspire Biopharma Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aspire Biopharma Holdings?
The stock symbol for Aspire Biopharma Holdings is "ASBP."
What Is the Aspire Biopharma Holdings Market Cap?
As of today, Aspire Biopharma Holdings market cap is 12.7100M USD.
What Is Aspire Biopharma Holdings's Earnings Per Share (TTM)?
The Aspire Biopharma Holdings EPS (TTM) is -33.3327.
From a Technical Analysis Perspective, Is ASBP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Aspire Biopharma Holdings Stock Split?
Aspire Biopharma Holdings has split 2 times.
What is the current trading status of Aspire Biopharma Holdings (ASBP)?
As of Sep 13, 2026, Aspire Biopharma Holdings (ASBP) is trading at a price of 9.0600 USD, with a previous close of 9.1200 USD. The stock has fluctuated within a day range of 9.0600 USD to 9.3783 USD, while its 52-week range spans from 3.3090 USD to 562.9200 USD.
What Is the ASBP Premarket Price?
ASBP's last pre-market stock price is 9.0900 USD. The pre-market share volume is 120.0000, and the stock has decreased by -0.0300, or -0.3300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.